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Abstract
Background: The patellofemoral joint (PFJ) is one compartment of the knee that is frequently
affected by osteoarthritis (OA) and is a potent source of OA symptoms. However, there is a dearth
of evidence for compartment-specific treatments for PFJ OA. Therefore, this project aims to
evaluate whether a physiotherapy treatment, targeted to the PFJ, results in greater improvements
in pain and physical function than a physiotherapy education intervention in people with
symptomatic and radiographic PFJ OA.
Methods: 90 people with PFJ OA (PFJ-specific history, signs and symptoms and radiographic
evidence of PFJ OA) will be recruited from the community and randomly allocated into one of two
treatments. A randomised controlled trial adhering to CONSORT guidelines will evaluate the
efficacy of physiotherapy (8 individual sessions over 12 weeks, as well as a home exercise program
4 times/week) compared to a physiotherapist-delivered OA education control treatment (8
individual sessions over 12 weeks). Physiotherapy treatment will consist of (i) quadriceps muscle
retraining; (ii) quadriceps and hip muscle strengthening; (iii) patellar taping; (iv) manual PFJ and soft
tissue mobilisation; and (v) OA education. Resistance and dosage of exercises will be tailored to
the participant's functional level and clinical state. Primary outcomes will be evaluated by a blinded
examiner at baseline, 12 weeks and 9 months using validated and reliable pain, physical function and
perceived global effect scales. All analyses will be conducted on an intention-to-treat basis using
linear mixed regression models, including respective baseline scores as a covariate, subjects as a
random effect, treatment condition as a fixed factor and the covariate by treatment interaction.
Conclusion: This RCT is targeting PFJ OA, an important sub-group of knee OA patients, with a
specifically designed conservative intervention. The project's outcome will influence PFJ OA
rehabilitation, with the potential to reduce the personal and societal burden of this increasing public
health problem.
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Background
Osteoarthritis (OA) is the leading cause of musculoskele-
tal pain and disability and is the third leading cause of life-
years lost due to disability in Australia, only behind
depression and dementia [1]. The annual total cost of
arthritic disease in Australia is estimated at $24 billion [2],
with the knee joint contributing substantially to this over-
all cost. The prevalence of OA in people aged over 55 years
is 20–26% and rising, with arthritis rates expected to
increase by 30% over the next 40 years [2]. The pain and
suffering endured by patients as a result of OA decreases
their quality of life, with the annual burden of disease
costs ($12 billion in Australia) being half the total costs
associated with this condition [2]. Pain associated with
daily activities such as walking and stair-climbing ulti-
mately leads to profoundly reduced functional independ-
ence [2].
The patellofemoral joint (PFJ) is one of the three knee
joint compartments. Awareness of its importance in the
OA process has been raised by the increasing use of lateral
and skyline x-rays in recent times. Research has revealed
that PFJ OA is more common than previously thought. In
a community-based study of knee OA (N = 218), the fre-
quency of radiographic osteophytes was greater in the PFJ
(65% knees) than in the tibiofemoral joint (TFJ) (55%
knees) [3]. Furthermore, in people with knee pain (N =
777), the most common compartmental distribution of
radiographic OA was a combination of TFJ and PFJ disease
(40%), followed by isolated PFJ OA (24%), and isolated
TFJ disease (4%) [4]. Within the PFJ, the lateral compart-
ment is more frequently affected by the OA process than
the medial [5,6]. Importantly, the presence of baseline PFJ
OA predicts structural deterioration in the TFJ compart-
ment over 30 months (OR 2.31, 95% CI 1.37, 3.88) [7].
The PFJ is an important source of symptoms associated
with knee OA [8]. Knee pain has been found to be signif-
icantly associated with PFJ osteophytes (OR 2.25, 95%CI
1.06, 4.77), but not TFJ osteophytes (OR 1.19, 95% CI
0.46, 3.09) [9], suggesting that the PFJ may be a more
important source of knee pain than the TFJ. Hunter et al
[10] noted that increased pain and poorer function was
associated with reduced cartilage volume in the patella,
but not in the femur nor the tibia. Other authors have
confirmed the relationship between radiographic PFJ OA
and knee pain [11-13].
Management strategies for knee OA have traditionally
focussed on alleviating symptoms, primarily using drug
therapies or surgery. A meta-analysis of OA trials high-
lights this, with most trials evaluating drug treatments
(60%) or surgical procedures (26%) [14]. OA experts have
highlighted the overall dearth of quality evidence to sup-
port the use of non-pharmacological interventions such as
physiotherapy. Despite this, knee OA clinical guidelines
recommend that conservative treatments be included as a
first line strategy for the optimal management of the dis-
ease [15,16]. Physiotherapy is a conservative intervention,
which is non-toxic, inexpensive and promotes physical
activity and self management through exercise. Therefore,
rigorous randomised clinical trials (RCTs) that evaluate
the efficacy of physiotherapy are clearly needed, to better
guide clinical decision-making.
Given the heterogeneity of knee OA with regard to aetiol-
ogy, clinical presentation and natural history, guidelines
also recommend the tailoring of knee OA treatments to
the location of joint damage in order to optimise treat-
ment outcomes [15,16]. However, most trials of physio-
therapy for knee OA have not been targeted to disease
subgroups, with participant selection typically based on
the presence of non-specific knee pain and radiographic
changes anywhere on an anteroposterior radiograph.
While a plethora of evidence attests to the benefits of exer-
cise for patients with predominant TFJ OA [17] there is no
level I evidence and only one RCT [18] specifically
addressing the problem of PFJ OA. The dearth of evidence
for a compartment-specific treatment for PFJ OA necessi-
tates our proposed study to establish the efficacy of a com-
partment-specific physiotherapy treatment using the
rigour of a RCT.
While there is little known about the physical impair-
ments associated with PFJ OA, there are several RCTs that
have evaluated physical interventions for PFJ pain in
younger adults (patellofemoral pain syndrome, or ante-
rior knee pain). We have previously conducted a double
blind, placebo-controlled RCT [19], which demonstrated
the efficacy of a targeted physiotherapy program for this
patient population. The targeted treatment involved (i)
quadriceps muscle retraining; (ii) patellar taping; (iii)
manual PFJ and soft tissue mobilisation; and (iv) hip
muscle retraining. We have recently confirmed the benefi-
cial effects of this targeted physiotherapy approach on
pain and physical function in another population of
young adults with PFJ pain [20]. Therefore, we are propos-
ing to evaluate a similar, targeted physiotherapy interven-
tion for people with PFJ OA.
This project aims to evaluate whether a physiotherapy
treatment, targeted to the PFJ and based on successful
treatment for PFJ pain in younger populations, results in
greater improvements in pain and physical function than
a physiotherapy education intervention in participants
with symptomatic and radiographic PFJ OA.BMC Musculoskeletal Disorders 2008, 9:122 http://www.biomedcentral.com/1471-2474/9/122
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Methods
Experimental design
A randomised, single-blind, controlled clinical trial con-
forming to CONSORT [21] guidelines will be conducted,
comparing a multimodal physiotherapy intervention to a
physiotherapy education intervention (Figure 1). A
Project Investigator will screen for eligibility based on his-
tory, clinical and radiographic examination.
Ethical approval has been obtained from the University of
Melbourne Human Research Ethics Committee (HREC
No. 0721163) and from the Department of Human Serv-
ices Victoria, Radiation Safety Committee. All participants
will provide written informed consent.
Participants
Ninety people with lateral PFJ OA will be recruited from
the community via advertisements, medical practitioners
and our own research database. To be included in the
study, participants must fulfil the following criteria: (i)
aged > 40 years; (ii) anterior- or retro-patellar knee pain
aggravated by at least two activities that load the PFJ (eg
stair ambulation, squatting and/or rising from sitting);
(iii) pain severity ≥ 4 on an 11 point numerical pain scale
during aggravating activities; (iv) pain during these activi-
ties present on most days during the past month; (v) oste-
ophyte grade ≥ 1 in the lateral PFJ compartment on
skyline x-ray [22].
Exclusion criteria will include: (i) concomitant pain from
other knee structures, hip or lumbar spine; (ii) current or
previous physiotherapy for knee pain (prior 12 months);
(iii) contra-indications to the treatments (eg tape allergy);
(iv) recent knee injections (prior 3 months); (v) planned
lower limb surgery in the following 9 months; (vi) body
mass index ≥ 35 kg.m2; (vii) medial PFJ OA (osteophytes
Flow of participants through the randomised controlled trial Figure 1
Flow of participants through the randomised controlled trial.
Telephone screening
Consent; X-ray and 
physical exam
screening
Baseline: baseline assessment (blinded assessor) and randomisation (N = 90)
Multi-modal 
physiotherapy
Ineligible
Fail inclusion criteria
Meet exclusion criteria
Ineligible
Fail inclusion criteria
Meet exclusion criteria
Physiotherapy 
education control
12 weeks: follow-up assessment (blinded assessor)
9 months: follow-up assessment (blinded assessor)BMC Musculoskeletal Disorders 2008, 9:122 http://www.biomedcentral.com/1471-2474/9/122
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or joint space narrowing on a skyline x-ray) that is more
severe than lateral PFJ OA; (viii) moderate to severe con-
comitant TFJ OA (Kellgren and Lawrence grade ≥ 3 on an
anteroposterior radiograph) [23]; (ix) knee or hip arthro-
plasty or osteotomy; (xi) physical inability to undertake
testing procedures or; (x) inability to understand written
and spoken English.
Sample Size
Treatment efficacy will be evaluated by comparing change
on primary outcome measures between groups. We aim to
detect the minimum clinically important improvement
on these outcomes as reported by Tubach et al [24]. Spe-
cifically, a sample of 90 will provide a minimum of 90%
power (α = 0.05) to detect a difference in pain on visual
analogue scale (VAS) of 19.9 (21.5) mm and a difference
in physical function on the Western Ontario MacMaster
Universities Osteoarthritis Index (WOMAC) [25] of 9.1
(13.9) normalised units. This sample size also allows for
an estimated 10% drop-out rate.
Procedure
The randomisation schedule (permuted blocks of 8 to 12)
will be generated and maintained centrally by one of the
investigators (BV), who will not be involved in assessment
of participants. The randomisation schedule will be
revealed via telephone following baseline assessment. A
blinded investigator will perform outcome assessments
(Table 1) at baseline, 12 weeks and 9 months, and partic-
ipants will be instructed not to divulge their group alloca-
tion. Security of the blinding system will be evaluated to
ensure integrity.
Outcome assessment
Age, gender, duration of knee OA symptoms, previous
treatment, surgery and medication use for knee OA will be
obtained at the baseline assessment.
Primary outcome measures: Pain and physical function
Overall average knee pain in the previous week on move-
ment and during an aggravating activity nominated by the
participant will be self-assessed with a 0–100 mm hori-
zontal visual analogue scale (VAS) with terminal descrip-
tors of (0 = no pain; 10 = maximal pain). Self-reported
Table 1: Outcome measures used in the randomised controlled trial
Primary Outcome Measurement
Usual pain on movement in the previous week 0–100 mm visual analogue scale (VAS) with terminal descriptors: 0 = no 
pain; 10 = maximal pain
Usual pain during nominated aggravating activity in the previous week 0–100 mm visual analogue scale (VAS) with terminal descriptors: 0 = no 
pain; 10 = maximal pain
Self reported difficulty with physical function Physical Function subscale of the Western and Onatario MacMasters 
University (WOMAC) Osteoarthritis Index (Likert version)
Secondary Outcomes Measurement
Symptoms
Pain and stiffness Pain and Stiffness subscales of the WOMAC
Perceived global effect score 5 point ordinal scale 
(1-much improved; 2-improved. 3-same; 4-worse; 5-much worse)
Sports and recreation function Sports and recreation function dimension of the Knee Injury and 
Osteoarthritis Score (KOOS)
Symptoms Symptoms dimension of the KOOS
Knee related quality-of-life Knee related quality-of-life dimension of the KOOS
Function
Lower extremity functional performance One-leg rise test – maximum number of one-leg rises from sitting on a 0.48 
m stool
Stair ambulation performance Timed stair ascent and descent
Standing balance Step test – number of times can step foot up and down off 15 cm step in 15 
s
Other Outcomes Measurement
Physical activity levels Physical Activity Scale for the Elderly (PASE)
Adherence (physiotherapy group only) Number of physiotherapy visits Completion of home exercises via log-
book
Knee-related medication use Log-book
Adverse effects Log-book and open probe questioningBMC Musculoskeletal Disorders 2008, 9:122 http://www.biomedcentral.com/1471-2474/9/122
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difficulty with physical function will be assessed using the
physical function subscale of the Likert version of the
WOMAC [25]. This disease-specific measure is reliable,
valid and responsive and comprises 17 items, using a 5-
point scale to score each, where higher scores indicate
worse symptoms.
Secondary outcome measures
Pain and stiffness will be assessed using the relevant sub-
scales of the WOMAC [25]. Participants will rate their per-
ceived overall change in symptoms following treatment
on a 5 point ordinal scale: 1-much improved, 2-improved,
3-no change, 4-worse, 5-much worse, giving a perceived
global effect score. Sports and recreation function, symptoms
and knee-related quality-of-life will be assessed using the rel-
evant dimensions of the Knee Injury and Osteoarthritis
Outcome Score (KOOS) [26].
Objective measures of function will include the one-leg rise
test, a timed stair ambulation test and the step-test. The
one-leg rise test is the maximum number of one-leg rises
the participant can perform from sitting on a stool. The
participant must hold their non-test leg out straight and
cannot use their arms for assistance. The number of rises
that the participant can complete will be recorded. This
test is a measure of lower extremity functional perform-
ance that has been found to predict the development of
radiographic knee OA in middle aged people with chronic
knee pain [27]. The timed stair ambulation task involves
the participant ascending and descending a set of nine
standard steps at their usual pace and the total time taken
recorded, with longer time taken indicating poorer physi-
cal function [28]. The step-test is a functional, dynamic
test of standing balance, where the participants stands on
one leg in front of a 15 cm step, and places the opposite
foot on and off the step as quickly as possible over 15 sec-
onds. The total number of successful steps are recorded,
with higher scores indicating better balance [29].
Other measures
Disease severity of the TFJ from weight bearing anteropos-
terior knee x-rays taken at screening will be determined
using the Kellgren and Lawrence grading system [23]
where 0 = normal; 1 = possible osteophytes; 2 = minimal
osteophytes and possible joint space narrowing; 3 = mod-
erate osteophytes, some narrowing and possible sclerosis
and; 4 = large osteophytes, definite narrowing and severe
sclerosis. PFJ OA will be assessed from a skyline x-ray
using a radiographic atlas [22]. The medial and lateral PFJ
compartments will each be scored separately for the pres-
ence of osteophytes and joint space narrowing where 0 =
normal; 1 = mild or 1–33% abnormal; 2 = moderate or
34–66% abnormal and; 3 = severe or 67–100% abnormal.
Co-interventions, adherence and adverse effects will also be
recorded. Participants will be asked to refrain from other
forms of OA treatment, but stable drug doses will be per-
mitted. Physiotherapists will record attendance, details of
treatment progression (physiotherapy group) and adverse
events. Participants will record adherence with home exer-
cises (physiotherapy group), adverse events and any co-
interventions, including knee-related medication use in a
log-book.
Interventions
Each participant will be treated by an experienced and reg-
istered physiotherapist. Treating practitioners will be
trained and proficient in both of the interventions (phys-
iotherapy and education control). Each treatment will be
delivered in 8 sessions over 12 weeks (once per week for
four weeks, then once every two weeks for 8 weeks). Rea-
sonable costs associated with treatments will be met by
the project.
Physiotherapy Treatment
The physiotherapy treatment will be similar to that
employed in our previous RCTs for patellofemoral pain in
younger people [19,20]. Treatment will consist of (i) func-
tional retraining exercises for the quadriceps muscle; (ii)
quadriceps and hip muscle strengthening; (iii) patellar
taping; (iv) manual PFJ and soft tissue mobilisation; and
(v) OA education. The treatment will be tailored accord-
ing to each participant's clinical presentation (eg strength,
pain severity, swelling) as well as the presence of co-mor-
bidities (eg back and hip pain or pathology), and will be
progressed based on individual response to exercise load,
thus optimising treatment effects. Exercises will be taught
and supervised by the physiotherapist during each visit. A
home exercise program will be prescribed, to be per-
formed independently at home 4 times per week. An exer-
cise manual for participants will be produced, with clear
instructions and diagrams to ensure correct and safe per-
formance of exercise. Specific aspects of the treatment are
outlined in Table 2 and will include:
(i) Functional retraining exercises for the quadriceps mus-
cle. The muscle retraining is designed to enhance the co-
ordination (magnitude and onset timing) of the medial
quadriceps, relative to the lateral utilising biofeedback
within the sessions. In order to accommodate a patient
group with heterogeneous symptoms, the functional
retraining exercises may be performed statically and/or
dynamically during various functional activities (eg step
up, step down, sit to stand).
(ii) Quadriceps and hip abduction strengthening. The
exercise selection will be based on baseline capacity of the
individual and then progressed, based on response to
exercise load, thus maximising the training effects. Resist-
ance will be provided by weights, rubber tubing and/or
body weight.BMC Musculoskeletal Disorders 2008, 9:122 http://www.biomedcentral.com/1471-2474/9/122
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(iii) Patellar taping to reduce pain using the same stand-
ardised protocol as per our previous knee OA research
[30,31]. The tape will be applied by the physiotherapist at
each visit, worn continuously for one week and then
removed.
(iv) Manual PFJ and soft tissue mobilisation, comprising
medial patellar glides and massage to the lateral soft tissue
structures, performed by the physiotherapist.
(v) OA education covering topics such as exercise, diet,
weight loss etc.
Following cessation of supervised physiotherapy sessions
at 12 weeks, participants will be instructed to continue
with a home exercise program. Adherence to the program
will be monitored from the diary recordings of exercise
completions.
Physiotherapy Education Control
In order to control for the psychosocial contact inherent
with the physiotherapy treatment, participants allocated
to the control group will attend individualised OA educa-
tion sessions covering topics such as exercise, diet, weight
loss, etc, provided by the physiotherapist with the same
frequency as the physiotherapy sessions.
Data quality and management
Strategies employed to ensure data quality include: (i)
training of assessors and physiotherapists; (ii) assessment
of procedural quality; (iii) random checks by investigators
of adherence to study protocols; and (iv) random checks
of forms for completeness and data for accuracy. All anal-
yses will be conducted on an intention-to-treat basis. The
primary outcomes measured at 12 weeks and 9 months
will be analysed using linear mixed regression models,
including their respective baseline scores as a covariate,
subjects as a random effect, treatment condition as a fixed
factor and the covariate by treatment interaction. Partici-
pant characteristics (eg; gender, radiographic severity of
TFJ and PFJ OA) will also be included as covariates.
Regression diagnostics will be used to check for normality
of the measures and homogeneity of variance, where
appropriate. Comparisons between group means will be
performed using Bonferroni or Newman Keuls range tests.
An alpha level of 0.05 will be used. Calculation of the
number needed to treat index will be performed to facili-
tate the development of clinical guidelines.
Discussion and Conclusion
PFJ OA is emerging as a distinct clinical entity that is com-
mon, is associated with considerable pain and disability,
and is an important and novel area of research, since little
is known about the optimal management of this condi-
tion. This study uses a single-blind RCT design to investi-
gate whether a multimodal physiotherapy treatment,
targeted to the PFJ, is more effective in reducing pain and
improving physical function than a physiotherapy educa-
tion control intervention in people with PFJ OA. As a sec-
ondary aim, it will evaluate whether the targeted
physiotherapy treatment results in greater perceived
improvement, self-reported stiffness, pain, sport and rec-
reational function, symptoms and knee-related quality of
life, as well as performance on functionally relevant tasks
(one-leg rises, timed stair ambulation, and step-test) than
the physiotherapy education control intervention.
Table 2: Physiotherapy treatment components
Functional retraining exercises† performed four times/week – participants perform a contraction of medial quadriceps in 
two of the following functional activities
- sitting (isometric)
- sit-stand
- step up
- single leg squat
Quadriceps muscle strengthening† performed four times/week – participants complete one exercise in each of the following
- inner range (open kinetic chain)
- mid range (open kinetic chain)
- weight-bearing (wall squat)
Hip abduction strengthening† performed four times/week
- sidelying hip abduction
Patellar taping
- combination of tilt, medial glide and fat pad unloading – tape will be applied by the physiotherapist at each visit, worn continuously for one 
week and then removed
-
Patellofemoral and soft-tissue mobilisation
- mobilisation of the patella (medial glides) performed by the physiotherapists
- massage to the painful and tight soft tissue structures, performed by the physiotherapist
†Exact exercise and its number of repetitions will be determined by the physiotherapist from a schedule of permissible exercises based on each 
participant's clinical presentation (eg strength, pain severity, swelling), presence of comorbidities (eg back and hip pain or pathology) and will be 
progressed based on individual response to exercise loadBMC Musculoskeletal Disorders 2008, 9:122 http://www.biomedcentral.com/1471-2474/9/122
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In contrast to OA primarily affecting the TFJ, compara-
tively little known about the features or impairments asso-
ciated with OA of the PFJ, and hence designing a targeted
intervention is challenging. Thus, we have chosen to
investigate a physiotherapy intervention that is largely
based on a program that we have previously found to be
successful in younger people with PFJ pain (patellofemo-
ral pain syndrome) [19,20]. Components of this targeted
intervention include: (i) functional retraining of the quad-
riceps muscle; (ii) quadriceps and hip muscle strengthen-
ing; (iii) patellar taping; (iv) manual PFJ and soft tissue
mobilisation; and (v) OA education. This intervention is
currently considered to be "best-practice" in the manage-
ment of PFJ pain, and is increasingly being employed clin-
ically in the management of people with PFJ OA.
An impairment that has been the subject of recent evalua-
tion in participants with generalised knee OA is patellar
malalignment. Patellar malalignment is typically exhib-
ited as lateral patellar tilt, displacement or subluxation
and may be important in PFJ OA by reducing and lateral-
ising the PFJ contact area [32], thus increasing stress in
this compartment. In people with knee OA, PFJ malalign-
ment has been shown to be associated with indices of OA
(joint space narrowing and loss of cartilage thickness)
[33,34] as well as progression of OA (joint space narrow-
ing) [35] in the PFJ compartment and increased func-
tional impairment [36]. Thus, PFJ malalignment is a key
feature of PFJ OA that could be amenable to a targeted
intervention such as physiotherapy. This supports the
inclusion of patellar tape in our targeted treatment, since
it has the potential to reduce patellar malalignment [37-
39] and we have already shown that patellar tape can
reduce knee pain in generalised knee OA populations
[30,31]. Other treatment modalities (eg PFJ and soft tissue
mobilisations), may assist in the treatment of PFJ pain
and malalignment in this patient population.
The balance of medial and lateral quadriceps activity is
essential to maintain PFJ alignment. Experimental studies
confirm that reduced or delayed medial quadriceps activ-
ity (relative to the lateral quadriceps) increases lateral
patellar malalignment, leading to areas of heightened
contact stress across the lateral PFJ compartment [40,41].
Thus, the balance of muscle activation between the
medial and lateral quadriceps may be important in PFJ
disease. In our studies of younger people with PFJ pain
[42,43], we have observed a temporal delay in medial
quadriceps activity. Thus, it is likely that individuals with
PFJ OA may require a specific retraining program designed
to restore balanced quadriceps activity.
While the role of hip muscle function in PFJ OA has not
been investigated, there is increasing evidence that hip
muscle function is impaired (reduced strength [44],
delayed hip muscle activity [45]; and altered hip move-
ments during ambulation [46]) in other PFJ conditions.
These studies indicate that hip abduction is particularly
relevant in patients with PFJ pain and hence, this study is
focusing on strengthening hip abduction. Furthermore,
the inclusion of a hip abduction strengthening program in
this study reflects contemporary clinical practice.
While the main goal of treatment for OA is to reduce pain
and disability, it is not known how non-pharmacological
interventions achieve this goal; such is the complex multi-
factorial nature of OA pain. Our intervention is based on
reversing the compartment-specific impairments likely to
be associated with PFJ OA. Furthermore, this intervention
builds on our previous studies, which have established
that: (i) taping the patella medially reduces pain and dis-
ability associated with non-specific knee OA [30,31,47]
and may reduce PFJ malalignment [48] and (ii) a quadri-
ceps retraining program can reduce pain and disability, as
well as restore quadriceps muscle activation patterns in
younger people with PFJ pain [19,49,50]. Our unique
RCT is targeting PFJ OA, an important sub-group of knee
OA, with a specifically designed intervention. The
project's outcome will influence knee OA rehabilitation,
thus reducing the personal and societal burden of this
increasing public health problem.
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